These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25364037)

  • 1. Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status.
    Mitchell SG; Gryczynski J; Kelly SM; O'Grady KE; Jaffe JH; Olsen YK; Schwartz RP
    J Drug Issues; 2014 Jan; 44(1):69-82. PubMed ID: 25364037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment.
    Kelly SM; Oʼgrady KE; Jaffe JH; Gandhi D; Schwartz RP
    J Addict Med; 2013; 7(2):133-8. PubMed ID: 23455877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment.
    Gordon MS; Vocci FJ; Taxman F; Fishman M; Sharma B; Blue TR; O'Grady KE
    Contemp Clin Trials; 2019 Apr; 79():21-27. PubMed ID: 30797042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans.
    Mitchell SG; Gryczynski J; Schwartz RP; O'Grady KE; Olsen YK; Jaffe JH
    Drug Alcohol Depend; 2013 Mar; 128(3):222-9. PubMed ID: 22999817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine Treatment for Probationers and Parolees.
    Gordon MS; Kinlock TW; Schwartz RP; Couvillion KA; Sudec LJ; O'Grady KE; Vocci FJ; Shabazz H
    Subst Abus; 2015; 36(2):217-25. PubMed ID: 24701967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid HIV testing for individuals on probation/parole: outcomes of an intervention trial.
    Gordon MS; Kinlock TW; McKenzie M; Wilson ME; Rich JD
    AIDS Behav; 2013 Jul; 17(6):2022-30. PubMed ID: 23536140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for opioid addiction in community corrections.
    Schwartz RP; Mitchell MM; O'Grady KE; Kelly SM; Gryczynski J; Mitchell SG; Gordon MS; Jaffe JH
    Int Rev Psychiatry; 2018 Oct; 30(5):117-135. PubMed ID: 30522370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROTOCOL: Opioid-specific medication-assisted therapy and its impact on criminal justice and overdose outcomes.
    Strange CC; Manchak SM; Hyatt JM; Haberman C; Desai A
    Campbell Syst Rev; 2021 Mar; 17(1):e1138. PubMed ID: 37050968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metropolitan context of substance use and substance use disorders among US adults on probation or parole supervision.
    Moore J; Renn T; Veeh C
    Subst Abus; 2022; 43(1):161-170. PubMed ID: 33848449
    [No Abstract]   [Full Text] [Related]  

  • 10. Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment.
    Nunes EV; Scodes JM; Pavlicova M; Lee JD; Novo P; Campbell ANC; Rotrosen J
    Am J Psychiatry; 2021 Jul; 178(7):660-671. PubMed ID: 34170188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on naltrexone in the criminal justice system.
    Patapis NS; Nordstrom BR
    J Subst Abuse Treat; 2006 Sep; 31(2):113-5. PubMed ID: 16919735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mental health treatment among older adults with mental illness on parole or probation.
    Bryson WC; Cotton BP; Barry LC; Bruce ML; Piel J; Thielke SM; Williams BA
    Health Justice; 2019 Mar; 7(1):4. PubMed ID: 30923982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A partnership approach to providing on-site HIV services for probationers and parolees: a pilot study from Alabama, USA.
    Lichtenstein B; Barber BW;
    J Int AIDS Soc; 2016; 19(4 Suppl 3):20868. PubMed ID: 27435709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone pharmacotherapy for opioid dependent federal probationers.
    Cornish JW; Metzger D; Woody GE; Wilson D; McLellan AT; Vandergrift B; O'Brien CP
    J Subst Abuse Treat; 1997; 14(6):529-34. PubMed ID: 9437624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.
    Booty MD; Harp K; Batty E; Knudsen HK; Staton M; Oser CB
    J Subst Use Addict Treat; 2023 Jun; 149():209051. PubMed ID: 37084815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward evidence-based practice for probationers and parolees mandated to mental health treatment.
    Skeem JL; Louden JE
    Psychiatr Serv; 2006 Mar; 57(3):333-42. PubMed ID: 16524990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid Misuse and Associated Health Risks among Adults on Probation and Parole: Prevalence and Correlates 2015-2020.
    Morrison M; Hai AH; Bandaru YS; Salas-Wright CP; Vaughn MG
    Subst Use Misuse; 2024; 59(1):20-28. PubMed ID: 37735916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study.
    Binswanger IA; Nguyen AP; Morenoff JD; Xu S; Harding DJ
    Addiction; 2020 Dec; 115(12):2329-2338. PubMed ID: 32267585
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.